SK

Sambit Karmakar

Director Director DIN 09723858
DIN 09723858 First appointment Sep 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2022
Shareholding value Locked Premium profile

About Sambit Karmakar

Data last updated:

Sambit Karmakar has 4 years in corporate governance. Formerly with 1 company, such as Dln Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09723858
Primary Designation Director
First Appointment 01 Sep 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Dln Drugs Private Limited U51909OR2022PTC040047
Director01 Sep 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dln Drugs Private Limited
Premium access

Shareholding and investment profile for Sambit Karmakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sambit Karmakar

Sambit Karmakar has 4 years in corporate governance. Formerly with 1 company, such as Dln Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Sambit Karmakar is associated with 0 companies as a director.

Sambit Karmakar has expertise in General Business.

Sambit Karmakar has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available